Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. - Wikidata - wikimedia - TriplyDB

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.

http://www.wikidata.org/entity/Q42276676

about

HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.HPV-associated lung cancers: an international pooled analysis.Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.Human papillomavirus and Epstein Barr virus in head and neck carcinomas: suggestions for the new WHO classification.Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples.Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.HPV Testing of Head and Neck Cancer in Clinical Practice.Tumor Staging and HPV-Related Oropharyngeal Cancer.Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC.The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.Human papillomavirus related oropharyngeal cancer.Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.Is immunohistochemical evaluation of p16 in oropharyngeal cancer enough to predict the HPV positivity?Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.Risk factors associated with competing mortality among patients with head and neck cancer in Japan.Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery.Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.Human papillomavirus in the nasopharynx: A true entity?The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival.Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?

P2860

Q26752584-78DA038D-AF40-4376-B17E-12FB8902E32A Q26830495-4C82CE25-210F-4C47-9EEA-342F260FDA97 Q27853077-65331E82-34A4-4EA9-97A8-3C779FEAA602 Q28076894-90F1324F-4733-46FE-A8A5-44B3B5300048 Q33655046-830E5E9B-727C-41F3-A970-BE46D2CFA9DB Q33705253-3766B063-CC3D-4C81-A04B-D0B2AF908D88 Q35052911-E27BAA76-7331-456A-9C7D-BE90B453ED22 Q35756867-44A4C397-653B-4D20-B93E-6A6AFBD69B3D Q35838231-449ADF11-1C25-4FE6-9FB2-4540EF31274D Q36105656-C139078D-C26A-47C9-BAA7-C5FE48731307 Q36285958-3DBC1D58-0761-41D1-A062-B10BD4EF8DE1 Q36783066-9A517411-C6F4-4D89-981A-EEC51AB0B91B Q37376041-DE80680C-9B78-4631-8190-44A900538A2C Q38255620-9DBEA854-0DFF-4661-A5EC-963AD177F2FA Q38372482-A3624386-C436-4927-AE3E-516AD4FDF7CC Q38557897-D07978C1-DBB8-49CA-B081-5AC3F8A78F6B Q38653658-12A51151-ABB6-4F45-924B-3EA6F5147C66 Q38971546-5E6F6DBC-1B53-4ED9-85F0-075E8281443E Q38971551-1AF8492D-001D-482E-B420-93C49E455EC1 Q38971577-FB591EED-B087-4D0B-B6FE-684C333B44FA Q39352364-4501477F-F055-4866-BF2D-8AB1C22036A4 Q40152615-6B5FB042-604F-400A-836E-BD7C0C58D948 Q40214883-3F049065-EE2B-4F1A-BCDE-C3959EC043B5 Q40219648-A61D6BC3-BCA2-4C70-9A76-CF2408D36D01 Q40534462-D839FF83-6B0F-4D1F-AFCC-90958C57ABFA Q40571255-91AB8EA8-1A69-4231-8A63-851EBFC32E6F Q41075136-76F4DBFD-4767-4111-B1D1-7C7700222B31 Q41372801-E060B319-0F4C-4E79-8FDA-7ECFE99F15F2 Q41750160-72F01739-98BA-4714-B2EB-9236BE2CC40C Q42254654-825AB6C4-A161-42A0-BC5D-BC3582CF364E Q47106465-20E143E2-C0C4-488D-8A4B-055E00C7ECFB Q47214971-61F9F6A6-C565-49A5-BC28-3369A756E5B3 Q47407081-3E436581-C943-4690-B5B4-3C8E494E9DF3 Q47423331-00CC401C-EA79-40A6-80A4-00566C75B4D6 Q48261359-941E18FC-DBC4-498B-80CD-4EC167076BE7 Q48277339-F5585F06-5F84-430A-9B6B-80339BE09BCB Q51846059-F442997F-1435-4B34-A5DD-2F20A29EEDF8 Q52583058-71B412CD-8A72-468B-B309-799D3339A62D Q53090717-18404B9E-2637-47CB-AFF3-6F68B920AC11 Q55246604-1A8C7C8F-7537-458F-9A97-3E721A4A8F48

P2860

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.

http://www.wikidata.org/entity/Q42276676

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Human papillomavirus detection ...... reatment De-escalation trials.

@en

Human papillomavirus detection ...... reatment De-escalation trials.

@nl

type

label

Human papillomavirus detection ...... reatment De-escalation trials.

@en

Human papillomavirus detection ...... reatment De-escalation trials.

@nl

prefLabel

Human papillomavirus detection ...... reatment De-escalation trials.

@en

Human papillomavirus detection ...... reatment De-escalation trials.

@nl

P1433

Q42276676-DBD7B467-B354-4114-9FA1-49034515C8CE

P1476

Q42276676-775CA1C8-C98A-45BA-925C-9D4A3641358F

P2093

Q42276676-15EA3212-FDB3-473A-B365-EADA6BDFD623

Q42276676-16F86B00-6B1E-4C0E-AF2A-9C41C8A5DAFE

Q42276676-3ADCAB7D-9EB5-415B-A480-94C87E384FC1

Q42276676-4D48DC80-37F6-4A5C-BDD3-29F0288B7E90

Q42276676-A9D9FF1C-2B9A-468B-A27B-7B9E33AB9996

Q42276676-BEF3111E-8011-494D-8A05-C448D12D7284

Q42276676-D52CD161-0CB5-4DEA-9FB6-72A3E6DA9F53

Q42276676-D737C81E-B151-42D2-8494-99E68EA1AAE9

Q42276676-E205F6BE-33BC-4B1B-8483-D79DACEEAF88

Q42276676-F8132576-B243-48A3-BF68-F147E9BF62C1

P2860

Q42276676-02821A76-14F3-4A25-ABE1-CF3DD39E5285

Q42276676-17E435FE-0095-4B29-94DF-4FC4E2E93A6B

Q42276676-4DFFA6D8-8027-41D2-BA88-5F8FFCF7EFDA

Q42276676-53797DEA-D240-4F8E-93A6-B7A0C2972B20

Q42276676-73A1D281-5F98-4AF8-AF67-CD6E95EFAE1A

Q42276676-7BD21AD9-8210-47DD-8BA4-9BD2DCFF21D3

Q42276676-7E13C78C-4ED8-4901-84A0-9B609A2FEC53

Q42276676-7E50C69F-D6FF-4C5F-8EE6-5D910E07A705

Q42276676-A284A828-44E9-4C45-A802-37419ACC0B1E

Q42276676-A76C0DC9-7D59-4A77-B71E-CA08CF28BD2B

P304

Q42276676-496DC43B-07EB-4F90-8D88-2B19D065D686

P31

Q42276676-AA7B5410-EE80-45FB-BC04-96F93EF97986

P356

Q42276676-952C68CE-F0DD-4EFD-9E1B-64878330483D

P433

Q42276676-65A15F0C-4C82-4B6D-8C20-1F7767FFDE0F

P478

Q42276676-63DBF8B6-A614-475B-A3F1-209554E1CDE1

P577

Q42276676-E302A2ED-D02E-4829-9EDA-B15C61B9E0C9

P698

Q42276676-5BBCC777-076D-4452-9EE9-927252495FC9

P356

P1433

Annals of Oncology

P1476

Human papillomavirus detection ...... reatment De-escalation trials.

@en

P2093

B I Witte

http://www.w3.org/2001/XMLSchema#string

C R Leemans

http://www.w3.org/2001/XMLSchema#string

D A M Heideman

http://www.w3.org/2001/XMLSchema#string

D Boon

http://www.w3.org/2001/XMLSchema#string

E Bloemena

http://www.w3.org/2001/XMLSchema#string

M M Rietbergen

http://www.w3.org/2001/XMLSchema#string

P J F Snijders

http://www.w3.org/2001/XMLSchema#string

R H Brakenhoff

http://www.w3.org/2001/XMLSchema#string

R J Baatenburg-de Jong

http://www.w3.org/2001/XMLSchema#string

S Koljenovic

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Human papillomavirus and survival of patients with oropharyngeal cancer.

Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer.

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus.

Bead-based multiplex genotyping of human papillomaviruses.

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

Comparison of Scoring Methods for ACE-27: Simpler Is Better.

P304

2740-2745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDT319

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23946330

http://www.w3.org/2001/XMLSchema#string